Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases

Autor: Dohm, Ammoren E., Nakashima, Justyn Y., Kalagotla, Hruday, Jiang, Shirley X., Tang, Joseph D., Bhandari, Menal, Kim, Youngchul, Graham, Jasmine A., Khushalani, Nikhil I., Forsyth, Peter A., Etame, Arnold B., Liu, James K., Tran, Nam D., Vogelbaum, Michael A., Wuthrick, Evan J., Yu, Hsiang-Hsuan Michael, Oliver, Daniel E., Ahmed, Kamran A.
Zdroj: In European Journal of Cancer October 2023 192
Databáze: ScienceDirect
Externí odkaz: